Bristol-Myers Squibb Company Ce (CELG-RI)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.88 USD | 30.64% |
| 2022 | 2.97 USD | -5.71% |
| 2021 | 3.15 USD | 179.15% |
| 2020 | -3.98 USD | -297.03% |
| 2019 | 2.02 USD | -33.33% |
| 2018 | 3.03 USD | 396.72% |
| 2017 | 0.61 USD | -77.15% |
| 2016 | 2.67 USD | 175.26% |
| 2015 | 0.97 USD | -19.83% |
| 2014 | 1.21 USD | -22.44% |
| 2013 | 1.56 USD | 33.33% |
| 2012 | 1.17 USD | -46.33% |
| 2011 | 2.18 USD | 20.44% |
| 2010 | 1.81 USD | -66.36% |
| 2009 | 5.38 USD | 103.02% |
| 2008 | 2.65 USD | 140.91% |
| 2007 | 1.10 USD | 35.8% |
| 2006 | 0.81 USD | -47.4% |
| 2005 | 1.54 USD | 25.2% |
| 2004 | 1.23 USD | -23.13% |
| 2003 | 1.60 USD | 55.34% |
| 2002 | 1.03 USD | -61.85% |
| 2001 | 2.70 USD | 12.5% |
| 2000 | 2.40 USD | 14.29% |
| 1999 | 2.10 USD | 32.91% |
| 1998 | 1.58 USD | -1.86% |
| 1997 | 1.61 USD | 13.38% |
| 1996 | 1.42 USD | 57.78% |
| 1995 | 0.90 USD | 0.0% |
| 1994 | 0.90 USD | -5.26% |
| 1993 | 0.95 USD | -1.04% |
| 1992 | 0.96 USD | -3.03% |
| 1991 | 0.99 USD | 17.86% |
| 1990 | 0.84 USD | 133.33% |
| 1989 | 0.36 USD | -40.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.60 USD | -27.71% |
| 2024 Q2 | 0.83 USD | 114.09% |
| 2024 Q1 | -5.89 USD | -777.01% |
| 2023 FY | - USD | 30.64% |
| 2023 Q2 | 0.99 USD | -8.33% |
| 2023 Q1 | 1.08 USD | 12.5% |
| 2023 Q4 | 0.87 USD | -7.45% |
| 2023 Q3 | 0.94 USD | -5.05% |
| 2022 Q1 | 0.60 USD | -45.45% |
| 2022 Q4 | 0.96 USD | 28.0% |
| 2022 FY | - USD | -5.71% |
| 2022 Q3 | 0.75 USD | 11.94% |
| 2022 Q2 | 0.67 USD | 11.67% |
| 2021 FY | - USD | 179.15% |
| 2021 Q1 | 0.90 USD | 120.22% |
| 2021 Q3 | 0.70 USD | 48.94% |
| 2021 Q4 | 1.10 USD | 57.14% |
| 2021 Q2 | 0.47 USD | -47.78% |
| 2020 Q1 | -0.34 USD | 38.18% |
| 2020 Q2 | -0.04 USD | 88.94% |
| 2020 Q3 | 0.83 USD | 2307.45% |
| 2020 FY | - USD | -297.03% |
| 2020 Q4 | -4.45 USD | -636.14% |
| 2019 FY | - USD | -33.33% |
| 2019 Q1 | 1.05 USD | 43.84% |
| 2019 Q2 | 0.88 USD | -16.19% |
| 2019 Q4 | -0.55 USD | -166.27% |
| 2019 Q3 | 0.83 USD | -5.68% |
| 2018 FY | - USD | 396.72% |
| 2018 Q4 | 0.73 USD | -37.07% |
| 2018 Q3 | 1.16 USD | 404.35% |
| 2018 Q2 | 0.23 USD | -74.73% |
| 2018 Q1 | 0.91 USD | 164.08% |
| 2017 Q2 | 0.56 USD | -41.05% |
| 2017 FY | - USD | -77.15% |
| 2017 Q4 | -1.42 USD | -373.08% |
| 2017 Q3 | 0.52 USD | -7.14% |
| 2017 Q1 | 0.95 USD | 79.25% |
| 2016 Q2 | 0.70 USD | -2.78% |
| 2016 Q1 | 0.72 USD | 960.22% |
| 2016 FY | - USD | 175.26% |
| 2016 Q4 | 0.53 USD | -26.39% |
| 2016 Q3 | 0.72 USD | 2.86% |
| 2015 Q2 | -0.08 USD | -111.27% |
| 2015 Q4 | -0.08 USD | -119.93% |
| 2015 Q3 | 0.42 USD | 625.0% |
| 2015 Q1 | 0.71 USD | 9002.56% |
| 2015 FY | - USD | -19.83% |
| 2014 FY | - USD | -22.44% |
| 2014 Q4 | 0.01 USD | -98.19% |
| 2014 Q3 | 0.43 USD | 115.0% |
| 2014 Q2 | 0.20 USD | -64.91% |
| 2014 Q1 | 0.57 USD | 29.55% |
| 2013 Q2 | 0.33 USD | -10.81% |
| 2013 Q3 | 0.42 USD | 27.27% |
| 2013 Q4 | 0.44 USD | 4.76% |
| 2013 FY | - USD | 33.33% |
| 2013 Q1 | 0.37 USD | -33.93% |
| 2012 Q3 | -0.43 USD | -213.16% |
| 2012 Q2 | 0.38 USD | -41.54% |
| 2012 Q1 | 0.65 USD | 30.0% |
| 2012 FY | - USD | -46.33% |
| 2012 Q4 | 0.56 USD | 230.23% |
| 2011 Q3 | 0.57 USD | 7.55% |
| 2011 Q2 | 0.53 USD | -8.62% |
| 2011 Q1 | 0.58 USD | 107.14% |
| 2011 FY | - USD | 20.44% |
| 2011 Q4 | 0.50 USD | -12.28% |
| 2010 Q4 | 0.28 USD | -49.09% |
| 2010 Q2 | 0.54 USD | 25.58% |
| 2010 FY | - USD | -66.36% |
| 2010 Q1 | 0.43 USD | -89.51% |
| 2010 Q3 | 0.55 USD | 1.85% |
| 2009 Q1 | 0.32 USD | -49.21% |
| 2009 Q2 | 0.66 USD | 106.25% |
| 2009 Q3 | 0.49 USD | -25.76% |
| 2009 Q4 | 4.10 USD | 736.73% |
| 2009 FY | - USD | 103.02% |
| 2008 Q1 | 0.33 USD | 833.33% |
| 2008 Q3 | 1.30 USD | 233.33% |
| 2008 FY | - USD | 140.91% |
| 2008 Q4 | 0.63 USD | -51.54% |
| 2008 Q2 | 0.39 USD | 18.18% |
| 2007 Q3 | 0.43 USD | 19.44% |
| 2007 FY | - USD | 35.8% |
| 2007 Q4 | -0.04 USD | -110.47% |
| 2007 Q2 | 0.36 USD | 2.86% |
| 2007 Q1 | 0.35 USD | 612.45% |
| 2006 Q1 | 0.36 USD | 38.46% |
| 2006 FY | - USD | -47.4% |
| 2006 Q4 | -0.07 USD | -140.18% |
| 2006 Q3 | 0.17 USD | -50.0% |
| 2006 Q2 | 0.34 USD | -5.56% |
| 2005 Q1 | 0.27 USD | 277.62% |
| 2005 Q4 | 0.26 USD | -46.94% |
| 2005 Q3 | 0.49 USD | -3.92% |
| 2005 FY | - USD | 25.2% |
| 2005 Q2 | 0.51 USD | 88.89% |
| 2004 Q4 | 0.07 USD | -81.67% |
| 2004 Q3 | 0.39 USD | 44.44% |
| 2004 Q2 | 0.27 USD | -46.0% |
| 2004 Q1 | 0.50 USD | 66.67% |
| 2004 FY | - USD | -23.13% |
| 2003 Q2 | 0.45 USD | 15.38% |
| 2003 FY | - USD | 55.34% |
| 2003 Q4 | 0.30 USD | -34.78% |
| 2003 Q3 | 0.46 USD | 2.22% |
| 2003 Q1 | 0.39 USD | 129.41% |
| 2002 Q4 | 0.17 USD | -5.56% |
| 2002 Q3 | 0.18 USD | -21.74% |
| 2002 Q2 | 0.23 USD | -23.33% |
| 2002 Q1 | 0.30 USD | -60.53% |
| 2002 FY | - USD | -61.85% |
| 2001 FY | - USD | 12.5% |
| 2001 Q4 | 0.76 USD | 18.75% |
| 2001 Q3 | 0.64 USD | 3.23% |
| 2001 Q2 | 0.62 USD | -10.14% |
| 2001 Q1 | 0.69 USD | 15.0% |
| 2000 FY | - USD | 14.29% |
| 2000 Q3 | 0.63 USD | 14.55% |
| 2000 Q4 | 0.60 USD | -4.76% |
| 2000 Q2 | 0.55 USD | -11.29% |
| 2000 Q1 | 0.62 USD | 16.98% |
| 1999 Q2 | 0.48 USD | -11.11% |
| 1999 FY | - USD | 32.91% |
| 1999 Q1 | 0.54 USD | 157.14% |
| 1999 Q3 | 0.55 USD | 14.58% |
| 1999 Q4 | 0.53 USD | -3.64% |
| 1998 Q3 | 0.49 USD | 16.67% |
| 1998 Q2 | 0.42 USD | -10.64% |
| 1998 FY | - USD | -1.86% |
| 1998 Q4 | 0.21 USD | -57.14% |
| 1998 Q1 | 0.47 USD | 17.5% |
| 1997 Q1 | 0.41 USD | 17.14% |
| 1997 FY | - USD | 13.38% |
| 1997 Q4 | 0.40 USD | -6.98% |
| 1997 Q3 | 0.43 USD | 16.22% |
| 1997 Q2 | 0.37 USD | -9.76% |
| 1996 Q4 | 0.35 USD | -7.89% |
| 1996 Q2 | 0.33 USD | -8.33% |
| 1996 Q1 | 0.36 USD | 609.92% |
| 1996 FY | - USD | 57.78% |
| 1996 Q3 | 0.38 USD | 15.15% |
| 1995 Q1 | 0.32 USD | 565.28% |
| 1995 Q4 | -0.07 USD | -120.76% |
| 1995 FY | - USD | 0.0% |
| 1995 Q3 | 0.34 USD | 13.33% |
| 1995 Q2 | 0.30 USD | -6.25% |
| 1994 Q3 | 0.31 USD | 14.81% |
| 1994 Q1 | 0.28 USD | 133.33% |
| 1994 FY | - USD | -5.26% |
| 1994 Q4 | 0.05 USD | -84.48% |
| 1994 Q2 | 0.27 USD | -3.57% |
| 1993 Q4 | 0.12 USD | -60.0% |
| 1993 Q2 | 0.26 USD | -7.14% |
| 1993 Q1 | 0.28 USD | 64.71% |
| 1993 FY | - USD | -1.04% |
| 1993 Q3 | 0.30 USD | 15.38% |
| 1992 Q4 | 0.17 USD | -41.38% |
| 1992 Q2 | 0.24 USD | -11.11% |
| 1992 Q1 | 0.27 USD | 12.5% |
| 1992 FY | - USD | -3.03% |
| 1992 Q3 | 0.29 USD | 20.83% |
| 1991 Q1 | 0.24 USD | 14.29% |
| 1991 Q4 | 0.24 USD | -11.11% |
| 1991 Q3 | 0.27 USD | 12.5% |
| 1991 FY | - USD | 17.86% |
| 1991 Q2 | 0.24 USD | 0.0% |
| 1990 FY | - USD | 133.33% |
| 1990 Q4 | 0.21 USD | -12.5% |
| 1990 Q1 | 0.20 USD | 217.65% |
| 1990 Q3 | 0.24 USD | 20.0% |
| 1990 Q2 | 0.20 USD | 0.0% |
| 1989 Q3 | 0.20 USD | 17.65% |
| 1989 Q1 | 0.17 USD | 21.43% |
| 1989 Q4 | -0.17 USD | -185.0% |
| 1989 FY | - USD | -40.0% |
| 1989 Q2 | 0.17 USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AbbVie Inc. | 2.73 USD | -42.125% |
| Bristol-Myers Squibb Company | 3.88 USD | 0.0% |
| Johnson & Johnson | 13.88 USD | 72.046% |
| Eli Lilly and Company | 5.80 USD | 33.103% |
| Merck & Co., Inc. | 0.14 USD | -2671.429% |
| Novartis AG | 7.15 USD | 45.734% |
| Organon & Co. | 4.01 USD | 3.242% |
| Pfizer Inc. | 0.38 USD | -921.053% |